Novavax Inc (NVAX)

203.24
-6.65(-3.17%)
  • Volume:
    3,522,454
  • Bid/Ask:
    202.00/203.00
  • Day's Range:
    198.01 - 215.24

NVAX Overview

Prev. Close
209.89
Day's Range
198.01-215.24
Revenue
919.45M
Open
212.06
52 wk Range
76.66-331
EPS
-9.25
Volume
3,522,454
Market Cap
15.06B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
10,815,219
P/E Ratio
-
Beta
1.62
1-Year Change
-96.45%
Shares Outstanding
74,080,008
Next Earnings Date
Nov 10, 2021
What is your sentiment on Novavax Inc?
or
Market is currently closed. Voting is open during market hours.

Novavax Inc News

Novavax Inc Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellNeutralBuyBuyStrong Buy
Technical IndicatorsSellStrong BuyStrong SellBuyStrong Buy
SummarySellBuyNeutralBuyStrong Buy

Novavax Inc Company Profile

Novavax Inc Company Profile

Employees
791

Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Read More
  • dun miss the opportunity.....will be double in few months.......once the production is maximize
    1
    • need to ramp up production line, time is ticking fast need to rush to capture unvaccinated individual .
      0
      • ‼️Nobody knows about when NVAX vaccine will be in serial production . Till now Novavax has NOT announced that it has submitted an EUA application. However, this week it is flying with the help of current rise momentum in vaccine stocks.
        0
        • this casino only try to deceive for money.
          1
          • when vaccine is available?
            1
            • buy more....... it is coming ........
              1
              • NVAX is just an elevator. Pumping and dumping never ends.
                2
                • https://www.investing.com/news/briley-financial-stick-to-their-buy-rating-for-novavax-2560149
                  0
                  • something coming out this week.
                    2
                    • Moderna 300 :)
                      0
                      • WHEN IS THE VACCINE AUTHORIZED?
                        0
                        • it's a scam to push a cultural shift. this has zero to do with a flu they call COVID. wake up sheep
                          3
                      • DOES ANYONE KNOW HOW TO WHEN THE EMERGENCY USE AUTHORIZATION FOR?
                        0
                        • Check premarket price of moderna guys. Just 280 :)
                          0
                          • Tomek Gr:)) we are from german descent.
                            0
                          • Thomas Müller I meant moderna  not you:)
                            0
                          • Get your commie facts straight.
                            0
                        • NVAX is a trash as I said before. The logical choice seems to be shifting investments to BNTX or MRNA before their official earning announcements in August.
                          4
                          • Funny i read on the same moderna comment board that moderna stock was trash 6 months ago, now its the best thing since slice bread
                            0
                          • Tomek GrMRNA may reach to 300 in the next 1-2 months and BNTX to 260-280. NVAX has been overpriced thus far. No NVAX vaccine yet. Facts are BNTX and MRNA.
                            1
                          • Tomek Grcheck premarket price of moderna Tomek. Just 280 :)
                            0
                        • ‼️Soon 160-165 level coming..
                          3
                          • any suggestions that this counter have chances to go up after few weeks or few months.
                            0
                        • ‼️NVAX does very slowly in the competition against MRNA and BNTX. Still they have NO authorization in US,UK and Europe. Shortly they have little chance for 2021 and also 2022.Competitiors are moving very fast with new agreements with the countries for rest of 2021 and 2022. Soon 160-165 level coming..
                          3
                          • what happened to the vaccine?no news?
                            0
                            • Haiiiii.......
                              0
                          • mrna rules
                            2
                            • alguno de ustedes tendra infirmacion acerca de la autorizacion de uso de emergencia
                              3
                              • some of you will have information about the emergency use authorization
                                2
                                • They said that for the third trimester they would request the emergency use of the vaccine, but they have not said if for July or September, I no longer like this, they are playing with us, the more time passes the less necessary the vaccine may be that many countries carry a good percentage of vaccinations to their population, and in other countries people no longer want to be vaccinated, specifically the US AND MEXICO
                                  3
                                  • dijeron que para el tercer trimestre solicitarian el uso de emergencia de la vacuna , pero no han dicho si para julio o para septiembre , esto ya no me agrada , estan jugando con nosotros , entre mas pasa el tiempo menos necesaria puede ser la vacuna , ya que muchos paises , llevan un buen porcentaje de de vacunacios a su poblacion , y en otros paise la gente ya no quiere vacunarse , en especifico EEUU Y MEXICO
                                    1
                                    • it doesn't look good....
                                      4
                                      • https://www.verywellhealth.com/novavax-vaccine-side-effects-5192068
                                        0
                                        • Oh my
                                          1
                                          Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
                                          Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.